Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Efgartigimod for Immune Thrombocytopenic Purpura
Recruiting1 awardPhase 3
Little Silver, New Jersey
"This trial is looking at how effective and safe efgartigimod IV is for people with primary immune thrombocytopenia. Participants will be randomly assigned to receive either efgart
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service